Browsing Tag
serplulimab
2 posts
Eisai and Shanghai Henlius Biotech enter Japan-focused licensing pact for serplulimab as PD-1 competition tightens
Discover how Eisai Co., Ltd.’s serplulimab licensing deal with Henlius could reshape Japan’s PD-1 oncology market and investor expectations.
Fosun Pharma signs licensing deal with Henlius Biotech for serplulimab
Fosun Pharma has signed an exclusive US licensing agreement with Shanghai Henlius Biotech for commercializing the latter’s serplulimab,…